← Browse by Condition
Medical Condition
myeloproliferative neoplasm
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2, Phase 2
NCT02402244
Recruiting
Project: Every Child for Younger Patients With Cancer
Enrollment
75,000 pts
Location
United States, Austr...
Sponsor
Children's Oncology Group
NCT03471260 Phase 1, Phase 2
Recruiting
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Enrollment
96 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05805605 Phase 2
Recruiting
Allo HSCT Using RIC and PTCy for Hematological Diseases
Enrollment
56 pts
Location
United States
Sponsor
Masonic Cancer Center, Univers...
NCT06131801
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Enrollment
68 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT03589729 Phase 2
Recruiting
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
Enrollment
100 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center